My Mission

To push the field of health services research forward, moving from merely surveilling health disparities, to actively crafting equitable solutions through policy.

I study the policy determinants of HIV, substance use disorder, and mental health disparities, especially among LGBTQ+ populations. In particular, I examine policy incentives aimed at increasing uptake of low-profit, but essential syndemic health services in the US safety-net.

Specialties

Econometric methods

Systematic review & meta-analysis

Grant writing

Course instruction and mentoring

Statistical programming (Stata, SAS)

LGBTQ+ health disparities

Syndemic of HIV, SUD, and MH

340B Drug Pricing Program

US Safety Net Healthcare Policy

Structural stigma and minority stress

Recent publications

Publications
Hostile Laws and Hospitalization

Dr. Scott Hadland and I document the potential harms of the wave of anti-LGBTQ, and in particular anti-trans, legislation that swept through state legislatures in 2022. We point out three ways healthcare professionals can advocate for the health of their LGBTQ patients.

Notice of Award for R36 dissertation grant from AHRQ

Notice of Award of federal R36 grant for dissertation project “Implications of the US 340B Drug Pricing Program for the Availability, Quality of Care, and Equitability of Syndemic (HIV/SUD/MH) health Services (340B AQCESS)”

Implementation and sustainability of safe consumption sites: a qualitative systematic review and thematic synthesis

Our thematic synthesis of qualitative literature identified engagement of PWUD and additional factors that appear to support SCS planning and operations and are critical to implementation success

Opportunities and challenges of generic Pre-Exposure Prophylaxis (PrEP) drugs for HIV

In this study, we examine early utilization patterns and prices for generic PrEP. We discuss the opportunities and challenges for generic PrEP to improve health among HIV vulnerable populations.

Dispensing of HIV and Hepatitis C Antivirals During COVID-19: An Interrupted Time-Series Analysis of U.S. National Data

U.S. dispensing of direct acting antiviral medications to treat HCV fell at the start of the U.S. COVID-19 outbreak and has yet to fully recover to pre-pandemic levels. Addressing barriers to care is crucial to reaching national HIV and hepatitis C elimination goals.

About me:

I am an applied health policy and public health researcher passionate about improving the health and wellbeing of marginalized populations. I study the policy determinants of HIV, substance use disorder, and mental health disparities, especially among LGBTQ+ populations. In particular, I examine policy incentives aimed at increasing uptake of low-profit, but essential syndemic health services in the US safety-net. My research uses state of the science econometric and systematic review methods to form the evidence base for effective and equitable health policies.

The overarching goal of my work is to push the field of health services research forward, moving from merely surveilling health disparities, to actively crafting equitable solutions through evidence-based policy.